Vir Biotechnology to Participate in Bank of America Securities 2026 Healthcare Conference
Vir Biotechnology announced that CEO Marianne De Backer will participate in a fireside chat at the Bank of America Securities 2026 Healthcare Conference on May 12. The session will be webcast live on the company's website and archived for 30 days following the event.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.